$3.3M to Fund Trial of Ai-Designed Bacteriophage Therapy for HAP/VAP
Locus Biosciences will conduct a clinical trial for its Ai-designed bacteriophage therapeutic for HAP/VAP caused by antibiotic-resistant P. aeruginosa.
Tag: hospital-acquired infections
All
Latest
$3.3M to Fund Trial of Ai-Designed Bacteriophage Therapy for HAP/VAP
Locus Biosciences will conduct a clinical trial for its Ai-designed bacteriophage therapeutic for HAP/VAP caused by antibiotic-resistant P. aeruginosa.
Read More
Specialized ET Tubes Not Superior to Standard ET Tubes
Polyurethane-cuffed endotracheal tubes with subglottic suction (PU-EVAC) did not reduce incidence of IVAC or possible VAP compared with a standard PVC ET tubes.
Read More
Hospital Halts Outbreak of P. aeruginosa
UCLA Health detected and halted a rare strain of Pseudomonas aeruginosa that carries a gene called NDM-1, or New Delhi metallo-β-lactamase.
Read More
Models Predict Pediatric Pneumonia Severity
Community-acquired pneumonia is one of the most common infections in children worldwide and represents one of the most frequent and costliest reasons US children are hospitalized.
Read More
Prior Antibiotic Exposure Linked to Increased Hospital-Onset Antimicrobial Resistant Infections During Pandemic
During the COVID-19 pandemic, hospital-onset antimicrobial-resistant (AMR) infections increased by 6.5% and remained 11.6% above baseline by March 2022.
Read More
Top 10 Patient Safety Threats
The ECRI’s annual list of patient safety threats includes healthcare-associated infections and medical misinformation, but it’s topped by a particular physician behavior towards patients and caregivers that can lead to a loss of trust.
Read More
Copper-Impregnated Surfaces Killed C. difficile Spores
A copper-impregnated surface significantly reduced C. difficile spores by over 97% within four hours, offering continuous antimicrobial protection.
Read More
Philips to Expand AI for Early Infection Detection Within Department of Defense
After successful development and pilot, technology using biomarkers from wearables to predict infection is set to expand within the US Department of Defense.
Read More
Pneumonia: Etiology, Care and Prevention
Pneumonia is a potentially life-threatening infection of the lungs that inflames alveoli and spurs the overproduction of purulent material. Typically afflicting neonates and seniors, the COVID pandemic has revealed the importance of proper pneumonia care for all patients.
Read More
Enzyme-Antibiotic Combo May Combat Ventilator-associated Pneumonia
A new model shows that combining antibiotics with enzymes improved the removal of tough biofilms in VAP, a finding that could lead to more effective treatments.
Read More
Hospital Stays Put Families at Risk of Superbug Infections, Study Finds
Family members of recently discharged patients face an increased risk of antibiotic-resistant infections, even if the patient was not diagnosed with the infection.
Read More
US Hospitals Slow to Adopt Newer Antibiotics for Highly Resistant Infections
Hospitals still treated over 40% of patients battling highly resistant infections exclusively with the older, generic agents, an NIH study finds.
Read More
Guidance to Reduce Infection Risk When Using Nebulizers
Researchers offer guidance on the safe use of nebulized therapies in healthcare settings and home environments.
Read More
Daily Toothbrushing Lowers Rates of Hospital-acquired Pneumonia
Toothbrushing also is associated with lower rates of ICU mortality, shorter duration of mechanical ventilation, and shorter ICU length of stay.
Read More
ReddyPort Releases 24-hour NIV Oral Care Kit
ReddyPort has released a 24-hour NIV Oral Care Kit, with a new soft-pack design enhanced to meet the special clinical needs of noninvasive ventilation patients.
Read More
AI Uncovers Promising Antibiotic to Fight Evasive Hospital Superbug
Scientists have used artificial intelligence to discover a new antibiotic that could be used to fight a deadly, drug-resistant pathogen that strikes vulnerable hospital patients.
Read More
Innoviva’s Bacterial Pneumonia Treatment Secures FDA Approval
Xacduro was approved for intravenous use in patients 18 years of age and older for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex.
Read More
RT 2023 May-June: The Digital Edition
In RT’s May-June 2023 issue, we cover the potential of vaping devices as smoking cessation aids; best practices for bubble CPAP use; plethysmography in the PFT lab; and infection control for intubated patients.
Read More
Additional Patent for ReddyPort NIV Oral Care Solutions
The US Patent Office issued US Patent No 11,324,910 to ReddyPort Inc to cover its positive pressure ventilation appliance modules and related systems and methods, the company reports.
Read More
Second US Patent for ReddyPort Elbow
The US Patent Office issued a patent to ReddyPort Inc, covering Positive Pressure Ventilation Elbow and Related Masks, Systems and Methods, according to the company.
Read More
Pneumonia: Short Antibiotic Course OK for Certain Cases
Pneumonia patients with normal oxygenation who were treated with an ‘ultrashort’ course of antibiotics compared with a longer course had similar outcomes, new research found.
Read More
RT 2022 May-June: The Digital Edition
In RT’s May-June 2022 issue, we cover the role respiratory therapists can play in lung ultrasound; high-flow oxygen for critical care COVID-19; and successful strategies for reducing VAE/VAP/HAP in the ICU.
Read More
New Guidance Released for Hospital-acquired Pneumonia Prevention
In the second in series of updates on guidance for infection control in acute-care hospitals, five medical organizations are recommending best practices for preventing hospital-associated pneumonia.
Read More
Alabama Hospital Adds ReddyPort Elbow, NIV Oral Care Solutions
Jackson Hospital (Montgomery, AL) selected ReddyPort Elbow in combination with ReddyPort NIV Maintenance products for patients on NIV without mask removal or interruption of CPAP or bi-level therapy.
Read More